[ET Net News Agency, 7 August 2026] HANSOH PHARMA (03692) rose 2.8% to HK$32.56.
It hits an intra-day high of HK$32.66, breaking above the 20-D SMA of HK$32.373, and an intra-day low of HK$31.3. The total shares traded was 3.75 million, with a value of HK$119.75m. The active buy/sell ratio is 66:34, with net buying turnover of HK$35.64m. HUATAI FIN HLDGS HK accounts for greatest net responsive buying turnover of HK$3.89m, with volume weighted average price of HK$31.897. J.P. MORGAN BRO (HK) accounts for greatest net responsive selling turnover of HK$8.51m, with volume weighted average price of HK$31.891. The stock has risen a combined 3.7% over the past 3 consecutive trading days.
The Hang Seng Index now rose 47 points, or 0.2% to 25,578; the Hang Seng China Enterprises Index now rose 10 points, or 0.1% to 8,509.
Basic Information| Nominal | 32.560 | % Chg | +2.78% |
| High | 32.660 | Low | 31.300 |
| Shares Tr | 3.75m | Turnover | 119.75m |
| 10-D SMA | 32.132 | %H.V | 32.321 |
| 20-D SMA | 32.373 | VWAP | 31.906 |
| 50-D SMA | 31.096 | RSI14 | 53.897 |
Status: Breaking above the 20-D SMA, active buy/sell ratio is 66:34, with net buying turnover of HK$35.64m, rising a combined 3.7% over the past 3 consecutive trading days
Performance of stocks in the same sector or of relevance| Stock (Code) | Price (HK$) | Change (%) |
|---|
| HANSOH PHARMA (03692) | 32.560 | +2.78 |
| SIHUAN PHARM (00460) | 0.900 | +3.45 |
| GRAND PHARMA (00512) | 5.185 | +1.47 |
| SBP GROUP (01177) | 5.040 | +2.23 |
| HENGRUI PHARMA (01276) | 58.300 | +3.37 |
| LIVZON PHARMA (01513) | 26.300 | +1.08 |
| LUYE PHARMA (02186) | 2.110 | +2.18 |
| FOSUN PHARMA (02196) | 16.930 | +3.36 |
| SH PHARMA (02607) | 11.880 | +0.68 |
| CHINARES PHARMA (03320) | 4.790 | +0.31 |
(ed)
